A weekly semaglutide injection pen in a refined specialist clinic setting
Medications

Wegovy

(Semaglutide)

Once-weekly injection pen

A once-weekly semaglutide injection considered within specialist-led, long-term weight care.

UK: licensed for weight management in eligible adults. Chennai: local availability, approved indications and suitability are confirmed individually by the clinic before prescribing.
Your care pathway

How treatment works here

01

It starts with a consultation

Nothing is prescribed without one.

02

A careful clinical assessment

A doctor reviews your medical history, current medicines, conditions and the factors driving your weight before any treatment is recommended.

03

Where treatment is appropriate

It is prescribed following your consultation. In the UK, treatment is dispensed by a licensed pharmacy and delivered to your address anywhere in the UK. In Chennai, it is collected in person from the clinic.

04

Reviewed before every supply

Nothing is issued on repeat without review. Before each supply you tell us how you are getting on, and a doctor reviews how you are responding, how you are tolerating treatment and anything that has changed before deciding.

United Kingdom · Chennai

What's Included

Your Wegovy Prescription Includes

Doctor-reviewed prescription

Every prescription follows individual review by a doctor and stays under ongoing clinical supervision.

Live online sessions with Dr Raj

Patients are invited to regular online education evenings and live Q&A sessions, covering nutrition, muscle preservation, managing side effects and planning for the long term.

Support between appointments

You can tell us about side effects or concerns at any point between consultations, not only at your next appointment.

How you receive your treatment

In the UK, dispensed by a licensed pharmacy and delivered to your door anywhere in the UK with tracked delivery. In Chennai, collected in person from the clinic.

About the Medication

What is Wegovy?

Wegovy contains semaglutide, a prescription medicine used alongside a reduced-calorie diet and increased physical activity for weight management in people who meet the licensed criteria.

This page covers the once-weekly Wegovy injection pen. A doctor reviews suitability, injection technique and ongoing monitoring before treatment.

It acts on the GLP-1 receptor, helping regulate appetite and food intake. Suitability depends on your medical history, current medicines, pregnancy plans and the balance of potential benefit and risk.

How Does It Work?

Appetite signalling

Semaglutide acts on GLP-1 receptors involved in appetite regulation, which may reduce hunger and food intake.

Fullness that lasts

Gastric emptying slows, so smaller portions feel satisfying for longer when combined with nourishing eating patterns.

Metabolic review

Changes in intake and weight can affect diabetes and blood-pressure treatment, so monitoring belongs inside the care plan.

Weekly injection pen beside a ceramic tray and fern
Using the injection

Your weekly injection routine

Wegovy is injected under the skin once a week. Follow the instructions for the pen supplied with your prescription and ask your clinical team to demonstrate the technique.

  1. Weekly penA pre-filled pen injected under the skin of the abdomen, thigh or upper arm, once a week on the same day.
  2. Gradual escalationThe injection starts at a low dose and increases gradually, guided by tolerance and clinical review.
  3. Rotate injection sitesFor the pen, change the site each week so the tissue stays healthy.
  4. Storage and disposalFollow the pen leaflet for refrigeration and storage, and use the sharps bin provided.
Clinical Evidence

How Effective is Wegovy?

In the STEP 1 trial, adults with obesity taking semaglutide 2.4mg alongside lifestyle support lost significantly more weight than those on placebo across 68 weeks. Averages describe study groups, not individuals.

14.9%
Average reduction at 68 weeks
2.4%
Placebo
~1 in 3
Lost 20% or more of body weight
68 wks
Trial duration

STEP 1, New England Journal of Medicine, 2021. Semaglutide has also been studied for cardiovascular outcomes in the SELECT trial, which was conducted in people without diabetes.

Dosing

How Do You Take Wegovy?

Wegovy is a once-weekly self-injection. Dose increases are gradual — normally at four-week intervals — and depend on tolerance and clinical review.

Most people reach a maintenance dose of 2.4mg. A prescriber may consider 7.2mg if needed after at least four weeks at 2.4mg, only for adults with obesity and an initial BMI of at least 30 — not adolescents or adults whose initial BMI was below 30.

Do not change your dose unless your doctor has told you to.

Available Doses

0.25mg
0.5mg
1mg
1.7mg
2.4mg
7.2mg

0.25mg is a starting dose only. 2.4mg is the usual maintenance dose; 7.2mg is a higher option used only where clinically appropriate, after review of response and tolerance.

Who Qualifies?

  • Adults meeting the licensed BMI and health criteria
  • A complete medical and medication review with no identified contraindication
  • Prepared for monitoring, nutrition support and long-term planning
  • Not pregnant, breastfeeding or trying to conceive

Book a consultation

Discuss your care with the clinic that is right for you.

Potential Side Effects

Like all medicines, Wegovy may cause side effects. Most are mild and settle as your body adjusts. Seek urgent medical help for severe, persistent abdominal pain, especially if it spreads to the back, with or without vomiting.

NauseaVomitingDiarrhoeaConstipationReduced appetiteFatigueIndigestionHeadache

Always read the Patient Information Leaflet. Contact your clinic or your doctor with any concerns.

Read the Wegovy injection patient information leaflet
Specialist Indications

How Wegovy is used across metabolic conditions

Semaglutide is prescribed within a wider clinical picture. Here is where it fits condition by condition, with published evidence for each.

Photographic portrait of a larger man in a teal sweater seated comfortably

Complex severe obesity

Obesity with several interacting drivers — hormonal, medication-related, psychological and metabolic.

Read the condition page

Where Wegovy fits: One component of a coordinated plan built after blood tests, alongside nutrition, movement and psychological support.

Published evidence
More than a prescription

The Specialist Weight Management Plan

The Specialist Weight Management Plan is our most intensive option for the most complex cases. Dr Raj recommends it after your initial consultation where it is the right level of support. Not everyone needs it. For others, consultations and review alone are enough, and what you are offered depends on what is actually going on.

Wegovy FAQs

Both contain semaglutide, but they have different licensed indications and prescribing information. They should not be treated as interchangeable without a prescriber.

The Wegovy injection is used once weekly, on the day agreed with your prescriber. Follow the leaflet for the pen supplied to you and do not change the dose without clinical advice.

Treatment starts at 0.25mg and steps up to a usual maintenance dose of 2.4mg. A prescriber may consider 7.2mg if needed after at least four weeks at 2.4mg, only for adults with obesity and an initial BMI of at least 30 — not adolescents or adults whose initial BMI was below 30.

Appetite signalling returns, so most people start to feel noticeably more hungry again, and weight regain is common. That is biology, not failure. This is why we plan the next stage before stopping: either a lower maintenance dose, a gradual taper, or a structured maintenance plan covering nutrition, protein intake, resistance exercise, sleep and regular review, so the result you worked for is protected.

No. Semaglutide must not be used during pregnancy and should be stopped before a planned pregnancy in line with current prescribing guidance.

From the clinic

Clinical Insights

Let's find out what's right for you

Treatment is one option among several, and which one suits you depends on your history, your other conditions and what has been tried before. That is what the consultation is for.